The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue

Bone Marrow Transplantation

Volumn 22, Issue 5, 1998, Pages 469-475

  Millar, B C ^a   Millar, J L ^a   Shepherd, V ^b   Blackwell, P ^b   Porter, H ^b   Cunningham, D ^b   Judson, I ^b   Treleaven, J ^b   Powles, R L ^b   Catovsky, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

CD33 ; CD34+; Peripheral blood stem cells; Platelet recovery

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN;

ARTICLE; CANCER PATIENT; COLONY FORMING UNIT GM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 0031708737     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701368     Document Type: Article

References (28)

1. Juttner CA, To LB, Roberts MM et al. Comparison of haematological recovery, toxicity and supportive care of autologous peripheral blood stem cells, autologous and allogeneic bone marrow transplants. Int J Cell Clon 1992; 10 (Suppl.): 160-161.
2. Jagganath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
3. Sheridan PW, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
4. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
5. Tricot G, Jagganath S, Vesole DH et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
6. + cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue. Bone Marrow Transplant 1996; 18: 871-878.
7. Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Leukemia Res 1996; 18 (Suppl. 1): S5-S7.
8. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 303-310.
9. + cell count. Bone Marrow Transplant 1997; 19: 1103-1110.
10. Watts MJ, Sullivan AM, Jamieson E et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and factors predicting for these parameters in 1010 pretreated patients with malignant lymphoma. J Clin Oncol 1997; 15: 535-546.
11. + cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony-stimulating factor. Hokkaido Igaku Zasshi 1996; 71: 771-783.
12. + peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression. Exp Haematol 1997; 25: 246-251.
13. + cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Stem Cells 1997; 15: 73-81.
14. Bradley TR, Hodgson GS, Rosenthal M. The effect of oxygen tension on haemopoietic and fibroblast cell proliferation in vitro. J Cell Physiol 1978; 97: 517-522.
15. Mariette X, Fermand J-P, Brouet J-C et al. Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated with high-dose therapy. Bone Marrow Transplant 1994; 14: 47-50.
16. Bird JM, Bloxham D, Samson D et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 1994; 88: 110-116.
17. Gribben JG, Freeman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation or infused hematopoietic harvest. New Engl J Med 1991; 325: 1525-1533.
18. Sharp JG, Kessinger A, Mann S et al. Outcome of high-dose theapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumour in the marrow or infused haematopoietic harvest. J Clin Oncol 1996; 14: 214-219.
19. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
20. Negrin RS, Kusnierz-Glaz CR, Still BJ et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 3334-3341.
21. Taylor K, Jagganath S, Spitzer G et al. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 1989; 7: 1791-1799.
22. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891-895.
23. Bensinger W, Appelbaum F, Rowley SD et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
24. de Sauvage F, Hass PE, Spencer SD et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
25. Lok S, Kaushansky K, Holly RD et al. Cloning and expansion of marine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
26. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand and thrombopoietin. Nature 1994; 369: 568-571.
27. Neelis KJ, Dubbelman YD, Qingliang L et al. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol 1997; 25: 1084-1093.
28. Neelis KJ, Dubbelman YD, Wognum AW et al. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high-dose total body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Exp Hematol 1997; 25: 1094-1103.